Abstract Two new 6-alkylsalicylic acids, salaceyins A and B were isolated by bioassay-guided fractionation from the culture of the endophytic Streptomyces laceyi MS53 and their structures were determined on the basis of spectroscopic data. Salaceyins A and B exhibited modest cytotoxicity against a human breast cancer cell line (SKBR3) with IC 50 values of 3.0 and 5.5 m g/ml, respectively.
Introduction
In our search for biologically active agents of natural origin, the culture broth of an endophytic actinomycete strain exhibited cytotoxic activity against a human breast cancer (SKBR3) cell line. Bioassay-guided fractionation of an EtOAc extract of a culture broth of Streptomyces laceyi MS53 resulted in the isolation of two new 6-alkylsalicylic acids (1 and 2, Fig. 1 ). Several 6-alkylsalicylic acid derivatives, biogenetically formed by the condensation of a fatty acid and three molecules of malonyl-CoA, have been isolated from plant sources including Anacardiaceae plants and Ginkgo biloba L., and exhibited antibacterial, antioxidant, insecticidal, and molluscidal activities [1ϳ9] . We report herein the isolation and structural determination of two new 6-alkylsalicylic acids, together with cytotoxic activities of the isolates against a human breast cancer cell line.
Results and Discussion
An endophytic Streptomyces strain (MS53) was isolated from a surface-sterilized stem of Ricinus communis L. Chemotaxonomic tests showed that the cell wall of the strain contained LL-diaminopimelic acid, indicating that it has cell-wall type I; no diagnostic sugars were detected in the hydrolysates of whole cells. Using partial 16S ribosomal DNA sequence analysis, the strain was identified to be closely related to Streptomyces laceyi. 1.23ϳ1 .35 (10H, multiplet, H-3Ј, 4Ј, 5Ј, 6Ј, and 7Ј) and 1.14 (2H, multiplet, H-8Ј)], suggested the presence of a 9-methyldecyl unit, which was substantiated by the 13 C NMR and mass spectra. The results obtained from the 1D and 2D NMR spectra indicated that compound 1 is a salicylic acid derivative with a 9-methyldecyl substitution in the molecule. The position of this alkyl group was determined unambiguously as C-6 by salient HMBC correlations (H-5/C-1, C-1Ј, H-1Ј/C-1, C-5, C-6). Therefore, the structure of the new compound, 1 was elucidated as 6-(9-methyldecyl)salicylic acid.
The
1 H and 13 C NMR spectra of compound 2 were almost superimposable with those of 1, except for the branch moiety of the 9-methyldecyl group of the latter compound. The absence of the iso-type methyl branch signals (9-methyldecyl unit) and the presence of the upfield shift signal for the terminal methyl group at d C 11.40 (C-11Ј) due to the g -effect of the methyl substitution at C-9Ј indicated that compound 2 has an anteisotype methyl branched chain rather than an iso-type 9-methyldecyl unit as in 1 [13] . The stereochemistry of C-9Ј position was inferred to be S based on the positive optical rotation of anteiso-type compounds [14] . Accordingly, the structure of the new compound, 2 was assigned as 6-(9 methylundecyl)salicylic acid and confirmed using HRFABMS and 2D NMR techniques.
Salaceyins A (1) and B (2) were evaluated against human breast cancer cell line (SKBR3) and both compounds exhibited modest cytotoxicity with IC 50 values of 3.0 and 5.5 m g/ml, respectively. Salicylic acids with alkyl side chains were previously reported to exhibit antibacterial and molluscidal activities [2ϳ4]. More specifically, anacardic acids isolated from Anacardiaceae plants showed synergistic antibacterial effects against methicillin-resistant Staphylococcus aureus, which has troubled hospitals worldwide with persistent infections [4, 5, 15, 16] . Therefore, it is obvious that more research is needed to investigate the antibacterial activity of 1 and 2.
Experimental
All melting points were determined on an Electrothermal 9100 instrument without correction. Optical rotation was measured on a JASCO P-1020 polarimeter. UV spectra were measured on a Shimadzu UV-1601 UV-visible spectrophotometer. NMR spectra were recorded on a Varian UNITY 400 spectrometer with CDCl 3 . ESI-MS and HRFABMS were obtained on Platform quadrupole and JMS-HX110A/HX110A Tandem Mass spectrometers, respectively. Preparative HPLC was carried out on a Varian system. Determinations of the isomer of diaminopimelic acid and the whole-cell sugar pattern were carried out as described by Hasegawa et al. using colonies from agar plates (ISP2 medium) [11] . A 16S rRNA gene sequence of strain MS53 was amplified by PCR using universal bacterial 16S rDNA primers (forward primer adapted from primer fD1 of Weisburg et al. [12] ; reverse primer adapted from primer p1525r of Chun and Goodfellow [10] ). The 16S rDNA was sequenced using a DNA automated sequencer (Applied Biosystems) and an Amersham Pharmacia Biotech Cy5 Thermo Sequenase dye terminator kit.
MS53 was cultured in a seed agar medium, ISP4. The fully grown mycelia or spore suspension was used to inoculate a 1000-ml baffled flask containing 300-ml of a seed medium consisting of yeast extract 0.3%, Bactopeptone 0.5%, malt extract 0.3%, glucose 1.0%, sucrose 10.3%, and MgCl 2 ·6H 2 O 0.1%, which is a modified YEME broth. The flasks were cultivated on a rotary shaker (170 rpm) for 3 days at 28°C. For the production cultures, 300 ml of the modified YEME medium in 1000-ml baffled flasks was inoculated with the seed culture, and the flasks were incubated at 28°C and 170 rpm for 7 days. The cultured broth (8 liters) was extracted with EtOAc twice and these extracts were filtered through a fritted funnel in vacuo to remove insolubles. The volume of the filtrate was reduced in vacuo and then partitioned between EtOAc and H 2 O to give the organic extracts (1.3 g). Fractionation of the EtOAc extract was initiated by Silica gel chromatography using a CHCl 3 -MeOH gradient as mobile phase, and fractions obtained were pooled based on TLC analysis. Fraction 4, eluted with CHCl 3 -MeOH (15 : 1), was passed through a Sephadex LH-20 column using [17] .
